UnitedHealth Stock News

UnitedHealth Group Incorporated delivered strong Q3 results, beating both revenue and earnings estimates and raising guidance, signaling a potential turnaround. UNH reported 12% year-over-year revenue growth and a 4% earnings per share beat, reversing a trend of recent estimate misses. The stock has outperformed the market recently, returning 22% in under three months compared to the S&P 500's ...

UnitedHealth on Tuesday raised its annual profit forecast and said it aims to grow in 2026, in a sign that the turnaround efforts under new CEO Stephen Hemsley were gaining steam.

America's biggest insurer is showing some signs of improvement in the health of its business, after a series of setbacks.

UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2025 Earnings Call October 28, 2025 8:00 AM EDT Company Participants Stephen Hemsley - CEO & Non-Independent Non-Executive Chairman Timothy Noel - Chief Executive Officer of UnitedHealthcare Business Patrick Conway - Chief Executive Officer of Optum Rx Wayne DeVeydt - Chief Financial Officer Krista Nelson - Chief Executive Officer of UnitedHealthca...

UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization.

UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) reported third-quarter revenue and adjusted earnings per share that beat Wall Street expectations, driven by growth in its health benefits and pharmacy services, and raised its full-year guidance. Revenue rose 12% from a year earlier to $113.2 billion, narrowly above analysts' estimate of $113.16 billion.

Shares of UnitedHealth Group Inc (NYSE:UNH) were last seen down 0.5% to trade at $364.11, after the company announced third-quarter results of $2.92 per share on $113.2 billion in revenue, the former beating estimates and the latter falling short.

UnitedHealth Group Incorporated delivered Q3 revenue of $113.2 billion, up 12.3% year-over-year, slightly ahead of consensus estimates despite ongoing regulatory and cost challenges. UNH's Q3 EPS of $2.92 beat expectations, signaling stabilization, while the medical care ratio remained elevated at 89.9% but in line with forecasts. Management raised 2025 guidance, expecting adjusted EPS of at le...